Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 10—October 2005


Botulinum Neurotoxin Detection and Differentiation by Mass Spectrometry

John R. Barr*Comments to Author , Hercules Moura*, Anne E. Boyer*, Adrian R. Woolfitt*, Suzanne R. Kalb*, Antonis Pavlopoulos*, Lisa G. McWilliams†, Jurgen G. Schmidt‡, Rodolfo A. Martinez‡, and David L. Ashley*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Battelle Memorial Institute, Atlanta, Georgia, USA; ‡Los Alamos National Laboratory, Los Alamos, New Mexico, USA

Main Article


Accuracy of quantification of BoNT-A*

Spike level (mouse LD50) Measured concentration mean SD (N = 4)
16 19.85 ± 1.71
32 33.75 ± 3.24
65 68.05 ± 5.07
125 120.78 ± 2.66

*BoNT, botulinum neurotoxin; LD, lethal dose; SD, standard deviation.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO